Dietary inorganic phosphate (Pi) (Pi)

Dietary inorganic phosphate in the gastrointestinal lumen represents the primary source of systemic phosphorus, an essential mineral for bone health, energy production, and cellular function [1]. In patients with impaired renal function, the inability to excrete excess phosphorus leads to hyperphosphatemia, which triggers a cascade of complications including secondary hyperparathyroidism and cardiovascular calcification [2][3]. This luminal phosphate is a critical therapeutic target for phosphate binders, which are non-absorbed agents designed to sequester phosphate within the gut [1]. By forming insoluble complexes, these drugs prevent the transport of phosphate across the intestinal epithelium into the bloodstream [2]. Managing luminal phosphate levels is a cornerstone of treatment for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) to improve patient outcomes and reduce mortality [3].

Other names

Intestinal phosphateLuminal phosphateOrthophosphateInorganic phosphorus

Phosphate binders act by ion exchange or chemical precipitation within the gastrointestinal lumen, forming insoluble complexes with dietary inorganic phosphate that are subsequently excreted in the feces, thereby reducing systemic absorption [1][2].